Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 Dec;69(6):792–798. doi: 10.1136/jnnp.69.6.792

Brain tumours in Sweden 1996: care and costs

P Blomqvist 1, J Lycke 1, P Strang 1, H Tornqvist 1, A Ekbom 1
PMCID: PMC1737161  PMID: 11080235

Abstract

OBJECTIVES—Brain tumours cause considerable concern due to a high mortality and there are increasing efforts to provide adequate care, sometimes outside hospitals. Health care utilisation, direct costs of care, and the indirect social cost of morbidity and early mortality caused by brain tumours in Sweden in the year 1996 was analysed.
METHODS—Quantification of ambulatory care, care in hospital, long term and palliative/terminal care, drug consumption, temporary as well as long term morbidity, and mortality from comprehensive national data sources. Direct costs were calculated using 1996charges. Indirect costs were calculated by sex and age specific salaries. A sensitivity analysis considered the impact of alternative estimates of each item.
RESULTS—Indirect costs were 75% of the total and were caused mainly by early mortality. Direct costs were predominantly for care in hospital, long term care, and home health care. Among direct costs, astrocytomas III-IV and meningiomas accounted for 42% and 30% respectively.
CONCLUSIONS—The cost of illness from brain tumours reflects the characteristics of these malignancies. Despite their low incidence rate, the economic impact caused by high mortality among young persons is a predominant trait. Costs of acute hospital care and also long term care and home care are considerable.



Full Text

The Full Text of this article is available as a PDF (124.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck-Friis B., Norberg H., Strang P. Cost analysis and ethical aspects of hospital-based home-care for terminal cancer patients. Scand J Prim Health Care. 1991 Dec;9(4):259–264. [PubMed] [Google Scholar]
  2. Beck-Friis B., Strang P. The family in hospital-based home care with special reference to terminally ill cancer patients. J Palliat Care. 1993 Spring;9(1):5–13. [PubMed] [Google Scholar]
  3. Beck-Friis B., Strang P. The organization of hospital-based home care for terminally ill cancer patients: the Motala model. Palliat Med. 1993;7(2):93–100. doi: 10.1177/026921639300700202. [DOI] [PubMed] [Google Scholar]
  4. Becker L. A., Green L. A., Beaufait D., Kirk J., Froom J., Freeman W. L. Detection of intracranial tumors, subarachnoid hemorrhages, and subdural hematomas in primary care patients: a report from ASPN, Part 2. J Fam Pract. 1993 Aug;37(2):135–141. [PubMed] [Google Scholar]
  5. Choucair A. K., Scott C., Urtasun R., Nelson D., Mousas B., Curran W. Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):9–20. doi: 10.1016/s0360-3016(97)00223-x. [DOI] [PubMed] [Google Scholar]
  6. Davis F. G., Freels S., Grutsch J., Barlas S., Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg. 1998 Jan;88(1):1–10. doi: 10.3171/jns.1998.88.1.0001. [DOI] [PubMed] [Google Scholar]
  7. Devaux B. C., O'Fallon J. R., Kelly P. J. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg. 1993 May;78(5):767–775. doi: 10.3171/jns.1993.78.5.0767. [DOI] [PubMed] [Google Scholar]
  8. Drummond M. F. Economics in cancer care. Eur J Cancer. 1995;31A(9):1387–1387. doi: 10.1016/0959-8049(95)00391-u. [DOI] [PubMed] [Google Scholar]
  9. Drummond M. Cost-of-illness studies: a major headache? Pharmacoeconomics. 1992 Jul;2(1):1–4. doi: 10.2165/00019053-199202010-00001. [DOI] [PubMed] [Google Scholar]
  10. Epstein M. E., Lindquist C. Cost accounting the Gamma Knife. Stereotact Funct Neurosurg. 1993;61 (Suppl 1):6–10. doi: 10.1159/000100652. [DOI] [PubMed] [Google Scholar]
  11. Ericsson J., Stenbeck M. Eye, brain and nervous system. Acta Oncol. 1995;34 (Suppl 4):83–93. doi: 10.3109/02841869509094063. [DOI] [PubMed] [Google Scholar]
  12. Fitzpatrick R., Davies L. Health economics and quality of life in cancer trials: report based on a UKCCCR workshop. United Kingdom Coordinating Committee on Cancer Research. Br J Cancer. 1998 May;77(10):1543–1548. doi: 10.1038/bjc.1998.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goddard M., Drummond M. The economic evaluation of cancer treatments and programmes. Eur J Cancer. 1991;27(10):1191–1196. doi: 10.1016/0277-5379(91)90078-r. [DOI] [PubMed] [Google Scholar]
  14. Gray D., MacAdam D., Boldy D. A comparative cost analysis of terminal cancer care in home hospice patients and controls. J Chronic Dis. 1987;40(8):801–810. doi: 10.1016/0021-9681(87)90132-9. [DOI] [PubMed] [Google Scholar]
  15. Hodgson T. A. Costs of illness in cost-effectiveness analysis. A review of the methodology. Pharmacoeconomics. 1994 Dec;6(6):536–552. doi: 10.2165/00019053-199406060-00007. [DOI] [PubMed] [Google Scholar]
  16. Kallio M. Therapy and survival of adult patients with intracranial glioma in a defined population. Acta Neurol Scand. 1990 Jun;81(6):541–549. doi: 10.1111/j.1600-0404.1990.tb01016.x. [DOI] [PubMed] [Google Scholar]
  17. Koopmanschap M. A., van Ineveld B. M. Towards a new approach for estimating indirect costs of disease. Soc Sci Med. 1992 May;34(9):1005–1010. doi: 10.1016/0277-9536(92)90131-9. [DOI] [PubMed] [Google Scholar]
  18. Layon A. J., George B. E., Hamby B., Gallagher T. J. Do elderly patients overutilize healthcare resources and benefit less from them than younger patients? A study of patients who underwent craniotomy for treatment of neoplasm. Crit Care Med. 1995 May;23(5):829–834. doi: 10.1097/00003246-199505000-00009. [DOI] [PubMed] [Google Scholar]
  19. McCusker J., Stoddard A. M. Effects of an expanding home care program for the terminally ill. Med Care. 1987 May;25(5):373–385. doi: 10.1097/00005650-198705000-00002. [DOI] [PubMed] [Google Scholar]
  20. Mehta M., Noyes W., Craig B., Lamond J., Auchter R., French M., Johnson M., Levin A., Badie B., Robbins I. A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):445–454. doi: 10.1016/s0360-3016(97)00071-0. [DOI] [PubMed] [Google Scholar]
  21. Modan B., Wagener D. K., Feldman J. J., Rosenberg H. M., Feinleib M. Increased mortality from brain tumors: a combined outcome of diagnostic technology and change of attitude toward the elderly. Am J Epidemiol. 1992 Jun 15;135(12):1349–1357. doi: 10.1093/oxfordjournals.aje.a116246. [DOI] [PubMed] [Google Scholar]
  22. Neymark N., Kiebert W., Torfs K., Davies L., Fayers P., Hillner B., Gelber R., Guyatt G., Kind P., Machin D. Methodological and statistical issues of quality of life (QoL) and economic evaluation in cancer clinical trials: report of a workshop. Eur J Cancer. 1998 Aug;34(9):1317–1333. doi: 10.1016/s0959-8049(98)00074-4. [DOI] [PubMed] [Google Scholar]
  23. Penar P. L. Cost and outcome analysis. Neurosurg Clin N Am. 1996 Jul;7(3):547–558. [PubMed] [Google Scholar]
  24. Penar P. L., Wilson J. T. Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation. Neurosurgery. 1994 May;34(5):888–894. doi: 10.1227/00006123-199405000-00016. [DOI] [PubMed] [Google Scholar]
  25. Pickard J. D., Bailey S., Sanderson H., Rees M., Garfield J. S. Steps towards cost-benefit analysis of regional neurosurgical care. BMJ. 1990 Sep 29;301(6753):629–635. doi: 10.1136/bmj.301.6753.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Polinsky M. N., Geer C. P., Ross D. A. Stereotaxy reduces cost of brain tumor resection. Surg Neurol. 1997 Dec;48(6):542–551. doi: 10.1016/s0090-3019(97)00365-0. [DOI] [PubMed] [Google Scholar]
  27. Preston-Martin S., Staples M., Farrugia H., Giles G. Primary tumors of the brain, cranial nerves and cranial meninges in Victoria, Australia, 1982-1990: patterns of incidence and survival. Neuroepidemiology. 1993;12(5):270–279. doi: 10.1159/000110328. [DOI] [PubMed] [Google Scholar]
  28. Ragnarson Tennvall G., Karlsson G. Cancer treatment in Sweden--costs of drugs, inpatient and outpatient care from 1985 to 1996 and cost effectiveness of new drugs. Acta Oncol. 1998;37(5):447–453. doi: 10.1080/028418698430395. [DOI] [PubMed] [Google Scholar]
  29. Rice D. P. Cost-of-illness studies: fact or fiction? Lancet. 1994 Dec 3;344(8936):1519–1520. doi: 10.1016/s0140-6736(94)90342-5. [DOI] [PubMed] [Google Scholar]
  30. Rutigliano M. J. Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation. Neurosurgery. 1994 Oct;35(4):797–798. doi: 10.1227/00006123-199410000-00045. [DOI] [PubMed] [Google Scholar]
  31. Rutigliano M. J., Lunsford L. D., Kondziolka D., Strauss M. J., Khanna V., Green M. The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors. Neurosurgery. 1995 Sep;37(3):445–455. doi: 10.1227/00006123-199509000-00012. [DOI] [PubMed] [Google Scholar]
  32. Sant M., Crosignani P., Bordo B. M., Nicola G., Bianchi M., Berrino F. Incidence and survival of brain tumors: a population-based study. Tumori. 1988 Jun 30;74(3):243–252. doi: 10.1177/030089168807400301. [DOI] [PubMed] [Google Scholar]
  33. Shugg D., Allen B. J., Blizzard L., Dwyer T., Roder D. Brain cancer incidence, mortality and case survival: observations from two Australian cancer registries. Int J Cancer. 1994 Dec 15;59(6):765–770. doi: 10.1002/ijc.2910590610. [DOI] [PubMed] [Google Scholar]
  34. Silverstein M. D., Cascino T. L., Harmsen W. S. High-grade astrocytomas: resource use, clinical outcomes, and cost of care. Mayo Clin Proc. 1996 Oct;71(10):936–944. doi: 10.1016/S0025-6196(11)63766-X. [DOI] [PubMed] [Google Scholar]
  35. Stiles C. D. Cancer of the central nervous system. Review of an AACR special conference in cancer research with the joint section on tumors of the AANS/CNS (San Diego, CA, June 7-11, 1997). Biochim Biophys Acta. 1998 Feb 20;1377(1):R1–10. doi: 10.1016/s0304-419x(97)00030-9. [DOI] [PubMed] [Google Scholar]
  36. Stommel M., Given C. W., Given B. A. The cost of cancer home care to families. Cancer. 1993 Mar 1;71(5):1867–1874. doi: 10.1002/1097-0142(19930301)71:5<1867::aid-cncr2820710525>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  37. Surawicz T. S., Davis F., Freels S., Laws E. R., Jr, Menck H. R. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol. 1998 Nov;40(2):151–160. doi: 10.1023/a:1006091608586. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES